Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06850116

Analysis of Immediate Urinary Continence Predictors After RS-RARP

This study is a retrospective, single-center clinical trial. It aims to retrospectively analyze the immediate postoperative urinary continence recovery in prostate cancer patients who underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' center. Based on the general conditions of patients, relevant perioperative clinical indicators, and parameters related to the sphincter and prostate gland measured by MRI, it explores the influencing factors of immediate urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in prostate cancer patients and constructs a relevant prediction model, thereby providing clinical guidance value for predicting immediate postoperative urinary continence recovery.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Prostate Cancer (Post Prostatectomy) Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Retzius-sparing Robot-assisted Radical Prostatectomy Urinary Continence Urogenital Diseases Urogenital Neoplasms

Sex eligibility

Male

Study type

Observational

Primary location

first hospital affiliated of Fujian medical university

Fuzhou, Fujian, 350005, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prostate cancer diagnosed by prostate biopsy and underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' hospital.
  • Received plain and contrast-enhanced pelvic or prostate MRI examinations before surgery.
  • Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1.
  • Complete clinicopathological data.
  • In good general condition, without infections, autoimmune diseases, hematological diseases or other malignant tumors.
  • Complete postoperative follow-up data, with a postoperative follow-up time of no less than 6 months.

Exclusion criteria

  • The patient has surgical contraindications.
  • The patient has contraindications for MRI examination.
  • Preoperative presence of congenital urinary system malformations, urinary incontinence or severe lower urinary tract symptoms, and with a history of urinary catheter or previous transurethral resection of the prostate (TURP) surgery.
  • Having received neoadjuvant treatments that may affect the results of this study, such as radiotherapy or hormonal therapy.
  • The patient has other concurrent malignant tumors.
  • The patient has delayed extubation (> 14 days).
  • The patient's clinical, imaging and pathological data are incomplete or the patient is lost to follow-up.

Treatment and study plan

Retzius-sparing robot-assisted radical prostatectomy

Procedure

Retzius-sparing robot-assisted radical prostatectomy

Primary outcomes

  1. rate of continence

    Time frame: rate of the preservation of urinary control function at 1 week after postoperative removal of the urinary catheter status

    Time Frame: 1 week after postoperative removal of the urinary catheter

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Fujian Medical University

Other

Registry information

Official study title

Analysis of Immediate Urinary Continence Predictors After Retzius-sparing Robot-assisted Radical Prostatectomy: A Single-center Retrospective Clinical Study

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Feb 27, 2025
Registry last updated
Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.